Enteral Feeding Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Enteral Feeding Pumps, Enteral Feeding Tubes, Other Product Types), Age Group (Adult and Pediatric), By Application (Diabetes, Neurological Disorders, And Cancer), By End Use (Hospital, Ambulatory Care Settings, And Home Care), By Region and Competition, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 4.87 Billion
CAGR (2026-2031)	5.49%
Fastest Growing Segment	Enteral Feeding Tubes
Largest Market	North America
Market Size (2031)	USD 6.71 Billion

Market Overview

The Global Enteral Feeding Devices Market is projected to grow from USD 4.87 Billion in 2025 to USD 6.71 Billion by 2031 at a 5.49% CAGR. Enteral feeding devices are medical instruments designed to deliver nutrition, fluids, and medications directly into the gastrointestinal tract for individuals unable to adequately consume or absorb nutrients orally. The market for these devices is primarily driven by the rising global prevalence of chronic diseases such as cancer and neurological disorders, an expanding geriatric population prone to malnutrition, and the increasing incidence of preterm births requiring specialized nutritional support. According to the National Home Infusion Association (NHIA), in 2024, approximately 234,070 individuals in the United States relied on home enteral nutrition.

A significant challenge impeding market expansion is the presence of insufficient reimbursement policies, especially in emerging economies. This issue creates substantial financial burdens for patients and caregivers, potentially restricting access to essential enteral nutrition therapy and hindering broader adoption of these critical medical devices.

Key Market Drivers

Rising chronic disease burden driving the need for direct enteral nutrition
The increasing prevalence of chronic diseases serves as a primary catalyst for the Global Enteral Feeding Devices Market. Conditions such as cancer, neurological disorders, and severe gastrointestinal issues frequently compromise a patient's ability to consume adequate oral nutrition, thereby necessitating direct enteral support. This growing disease burden leads to a heightened demand for devices that facilitate the delivery of essential nutrients directly into the gastrointestinal tract. For instance, according to the American Heart Association, in March 2026, its "diabetes 2024 statistics infographic" indicated that 29.3 million adults in the United States have been diagnosed with diabetes, many of whom may eventually require specialized nutritional management due to complications or comorbidities. The consistent rise in such chronic conditions globally underscores the sustained need for enteral feeding solutions.

Aging population and elevated malnutrition risk
Concurrently, the expanding geriatric population significantly influences the market's trajectory, as older adults are inherently more susceptible to conditions leading to malnutrition and dysphagia. As individuals age, physiological changes often impair their nutritional intake and absorption, making enteral feeding devices crucial for maintaining health and supporting recovery. According to a systematic review and meta-analysis published in Public Health in Practice in March 2026, the global prevalence of malnutrition in the elderly was found to be 18.6%, highlighting a substantial population in need of nutritional intervention. Furthermore, industry commitment to advancing clinical nutrition is evident; according to Fresenius Kabi, in January 2026, a press release detailed the ESICM–Fresenius Kabi Medical Nutrition Research Grant, which provided a €20,000 grant in 2025 to support innovative projects in intensive care nutrition. This investment reflects ongoing efforts to improve nutritional care, further stimulating the development and adoption of advanced enteral feeding devices.

Download Free Sample Report

Key Market Challenges

The challenging factor is insufficient reimbursement policies. These policies directly impede the expansion of the global enteral feeding devices market by creating substantial financial obstacles for both patients and their caregivers. When coverage for enteral nutrition therapy and associated devices is inadequate or inconsistent, particularly in emerging economies, the out-of-pocket costs become prohibitive. This financial strain often leads to delayed initiation or complete avoidance of crucial enteral nutrition, despite medical necessity.

This challenge significantly restricts the broader adoption of these medical devices and limits market penetration. According to the National Home Infusion Association (NHIA), in 2025, one in four home enteral nutrition providers reported considering or actively planning to discontinue providing enteral nutrition formulas or supplies due to cost pressures. Such decisions by providers directly reduce the availability of essential enteral feeding devices and related services, thus hampering the overall market growth by limiting access for individuals who require specialized nutritional support.

Key Market Trends

Technological innovations in device design and functionality represent a significant trend reshaping the global enteral feeding devices market, emphasizing enhanced safety, patient comfort, and smart features. The integration of advanced capabilities, such as real-time monitoring and data-driven insights, aims to improve the precision and effectiveness of nutritional delivery systems. For example, according to AdvaMed, in April 2026, a press release announced that Gravitas Medical, Inc. initiated a clinical study to evaluate its next-generation smart feeding tube system in neonatal and infant patients, enrolling up to 100 patients. This focus on sophisticated device engineering directly addresses clinical needs for safer and more intuitive enteral feeding solutions.

Concurrently, the growing adoption of enteral feeding devices in homecare and alternate care settings is a pivotal trend expanding market reach beyond traditional hospital environments. This shift is driven by patient preference for care in familiar surroundings and the development of portable, user-friendly devices suitable for non-clinical use. Companies are responding with tailored product portfolios to support this transition. For instance, according to Food and Drink Digital, in April 2026, an article reported that in 2025, sales of Nestlé's Compleat real food tube-feeding solutions increased by approximately one-third, reflecting the rising demand for home-based nutritional support options.

Segmental Insights

The Enteral Feeding Tubes segment is experiencing rapid growth within the Global Enteral Feeding Devices Market. This acceleration is primarily driven by the increasing prevalence of chronic conditions, such as cancer and neurological disorders, which often impair a patient's ability to swallow or digest food normally, necessitating alternative nutritional support. Furthermore, a rising global geriatric population, frequently prone to dysphagia and malnutrition, significantly boosts the demand for these devices. Technological advancements, including improved safety connectors and anti-clog designs, also enhance the usability and broaden the adoption of enteral feeding tubes in both clinical and home care settings.

Regional Insights

North America leads the Global Enteral Feeding Devices Market due to its advanced healthcare infrastructure and strong reimbursement policies that facilitate access to essential nutritional support. The region also benefits from a high prevalence of chronic diseases, such as cancer and neurological disorders, alongside a substantial geriatric population requiring long-term nutritional intervention. Additionally, rising awareness among healthcare professionals and patients regarding the benefits of enteral nutrition, combined with ongoing technological advancements, further solidifies North America's dominant market position.

Recent Developments

• In April 2026, Gravitas Medical announced the commencement of a prospective, multicenter clinical study evaluating its next-generation smart feeding tube system, the Gravitas Entarik™ Feeding Tube System, in neonatal and infant patients. This breakthrough research initiative aimed to assess the safety and effectiveness of the FDA-cleared device, which had also received Breakthrough Device Designation. The Entarik system provides real-time guidance during tube placement and continuous monitoring of tube position and gastric activity, addressing critical patient safety concerns related to feeding tube misplacement and potential complications in vulnerable patient populations.
• In April 2026, Luminoah received U.S. Food and Drug Administration (FDA) clearance for its Luminoah Flow™ Enteral Nutrition System. This new product launch represents a significant advancement in the enteral feeding devices market, focusing on improving the patient experience. The Luminoah Flow system integrates portability, precision, and connected technology into a streamlined platform. It is designed to simplify nutrition delivery, enhance safety, and enable more personalized care by offering features like real-time data tracking and a modern touchscreen pump interface, thereby supporting both patients and healthcare providers.
• In January 2026, ENvue Medical launched a new line of over-the-counter (OTC) ENFit syringes for enteral feeding and medication delivery. These syringes became available without a prescription and were offered in various sizes, including 2.5 mL, 5 mL, 10 mL, and 60 mL. Designed to comply with ISO 80369-3 global standards, the syringes are reusable for up to seven days or 20 uses, thereby promoting continuity of care across both clinical and home environments. The introduction of these accessible, standardized devices aimed to enhance patient and caregiver support for safe enteral delivery.
• In February 2025, Cardinal Health announced the international expansion of its innovative Kangaroo OMNI™ Enteral Feeding Pump, initiating launches across Europe, Australia, and New Zealand. This expansion into key global markets followed its earlier introduction in the United States and Canada in 2023. The Kangaroo OMNI™ system is a portable and independent enteral feeding solution, designed to deliver a variety of formulas, including thick, homogenized, and blended options. This product launch aimed to provide patients with greater flexibility and personalized choices throughout their enteral feeding journeys by supporting diverse nutritional requirements and care settings.

Key Market Players

• Fresenius SE & Co. KGaA
• Applied Medical Technology Inc.
• Boston Scientific Corporation
• Amsino International, Inc.
• CONMED Corporation
• Danone S.A.
• Cook Medical, Inc.
• B. Braun Melsungen AG
• Nestlé S.A.
• Avanos Medical, Inc.

By Type	By Application	By End Use	By Region
Enteral Feeding Pumps Enteral Feeding Tubes Other Product Types	Diabetes Neurological Disorders Cancer	Hospital Ambulatory Care Settings Home Care	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Enteral Feeding Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Enteral Feeding Devices Market, By Type:

• Enteral Feeding Pumps
• Enteral Feeding Tubes
• Other Product Types

• Enteral Feeding Devices Market, By Application:

• Diabetes
• Neurological Disorders
• Cancer

• Enteral Feeding Devices Market, By End Use:

• Hospital
• Ambulatory Care Settings
• Home Care

• Enteral Feeding Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE